Watch Dave Aguilera's Forecast ...
Monday, March 9th ...
Durable 76% complete response (CR) rate at 12 months with 95% CR rate at any time in high-risk NMIBCBCG-unresponsive patients achieved an 80% CR rate at 12 months and 94% CR rate at any time ...
The Atlas AI Studio platform has moved from beta to production after demonstrating 10-50x faster asset creation with AAA ...
Although the Graves disease treatment landscape remains challenging, emerging therapies could shift existing treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results